MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Novavax Inc

Fermé

SecteurSoins de santé

5.97 -0.67

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.66

Max

6.22

Chiffres clés

By Trading Economics

Revenu

40M

-81M

Ventes

3.8M

88M

BPA

-0.52

Marge bénéficiaire

-91.755

Employés

952

EBITDA

52M

-53M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+146.66% upside

Dividendes

By Dow Jones

Prochains Résultats

9 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-140M

1.1B

Ouverture précédente

6.64

Clôture précédente

5.97

Sentiment de l'Actualité

By Acuity

93%

7%

372 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Novavax Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 avr. 2025, 17:06 UTC

Principaux Mouvements du Marché

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mars 2025, 14:19 UTC

Principaux Mouvements du Marché

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 févr. 2025, 18:52 UTC

Principaux Mouvements du Marché

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov. 2024, 14:05 UTC

Principaux Mouvements du Marché

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 oct. 2024, 12:59 UTC

Principaux Mouvements du Marché

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13 mai 2024, 18:14 UTC

Principaux Mouvements du Marché

Novavax Shares Pop Another 50% Following Sanofi Deal

10 mai 2024, 10:59 UTC

Principaux Mouvements du Marché

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30 déc. 2024, 23:02 UTC

Acquisitions, Fusions, Rachats

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 déc. 2024, 07:09 UTC

Acquisitions, Fusions, Rachats

Novavax: Agreement to Close by Dec 30 >NVAX

4 déc. 2024, 07:08 UTC

Acquisitions, Fusions, Rachats

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 déc. 2024, 07:07 UTC

Acquisitions, Fusions, Rachats

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 déc. 2024, 07:06 UTC

Acquisitions, Fusions, Rachats

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 déc. 2024, 07:06 UTC

Acquisitions, Fusions, Rachats

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 déc. 2024, 07:04 UTC

Acquisitions, Fusions, Rachats

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov. 2024, 13:34 UTC

Actualités

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 oct. 2024, 15:22 UTC

Résultats

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10 mai 2024, 20:11 UTC

Résultats

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Résultats
Actions en Tendance

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10 mai 2024, 10:47 UTC

Acquisitions, Fusions, Rachats

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Comparaison

Variation de prix

Novavax Inc prévision

Objectif de Prix

By TipRanks

146.66% hausse

Prévisions sur 12 Mois

Moyen 14.75 USD  146.66%

Haut 19 USD

Bas 9 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

N/A / 7.011Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

372 / 386Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.